DNTH
Dianthus Therapeutics, Inc. · Healthcare
EVP, Head of R&D Simrat Randhawa sold $2.4M of Dianthus Therapeutics, Inc.
Sold$2,404,077
$90.62Price
26,530Shares
−87%Stake
What DNTH did after the filing
- The stock from Wed, Jun 3 open, $82.51
- +28.0%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Jul 17 close.
Traded Mon, Jun 1. Filed Tue, Jun 2, 7:00 PM ET, after the close. Returns use the Jun 3 open and the Jul 17 close. Not investment advice.